Alliancebernstein L.P. Has $35.12 Million Holdings in STERIS plc (NYSE:STE)

Alliancebernstein L.P. lessened its stake in shares of STERIS plc (NYSE:STE - Free Report) by 88.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 170,831 shares of the medical equipment provider's stock after selling 1,276,086 shares during the quarter. Alliancebernstein L.P. owned about 0.17% of STERIS worth $35,116,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in STE. Avalon Trust Co acquired a new position in STERIS in the fourth quarter worth approximately $30,000. Human Investing LLC purchased a new position in STERIS during the 4th quarter worth approximately $31,000. Anfield Capital Management LLC grew its position in STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after purchasing an additional 91 shares in the last quarter. Central Pacific Bank Trust Division grew its position in STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock worth $39,000 after purchasing an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC grew its position in STERIS by 182.7% during the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock worth $44,000 after purchasing an additional 137 shares in the last quarter. Institutional investors and hedge funds own 94.69% of the company's stock.

Analyst Ratings Changes

Several equities analysts have weighed in on STE shares. Piper Sandler lifted their price objective on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. Needham & Company LLC reissued a "hold" rating on shares of STERIS in a research note on Monday. JMP Securities reissued a "market outperform" rating and set a $265.00 target price on shares of STERIS in a research note on Thursday. Finally, Stephens reissued an "overweight" rating and set a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $258.75.

Remove Ads

STERIS Stock Performance

STE traded down $6.97 during trading on Thursday, hitting $215.98. The stock had a trading volume of 156,849 shares, compared to its average volume of 535,294. The firm has a market cap of $21.22 billion, a PE ratio of 45.99 and a beta of 0.87. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The company has a 50 day simple moving average of $222.60 and a 200-day simple moving average of $219.88.

STERIS (NYSE:STE - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Analysts expect that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were paid a $0.57 dividend. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.06%. STERIS's payout ratio is currently 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.